Genetic Disorders and Biochemical Pathology Practice Questions

Q: A 4-year-old girl presents with sudden onset of right hip pain. Examination reveals a dislocated right hip. She can bend her thumb backward to touch her forearm, and her skin is extraordinarily stretchable. Spinal radiographs show marked lateral and anterior curvature. She develops retinal detachments later in childhood. A sibling is similarly affected, and a mutation in tenascin-X is identified. What is the most likely underlying cause for this child's findings?

Deficient collagen synthesis. **Explanation:** The clinical presentation of hypermobile joints (thumb touching the forearm), hyperextensible skin, hip dislocation, and scoliosis (spinal curvature) is classic for **Ehlers-Danlos Syndrome (EDS)**. EDS is a heterogeneous group of connective tissue disorders primarily caused by **deficient collagen synthesis** or defects in collagen-modifying enzymes. The specific mention of a **tenascin-X mutation** points toward the **classical-like EDS (clEDS)**. Tenascin-X is a glycoprotein that organizes collagen fibrils in the extracellular matrix; its deficiency leads to reduced collagen density in tissues. Retinal detachment, though more common in Stickler syndrome or Marfan syndrome, can occur in severe EDS variants due to fragile ocular connective tissue. **Why incorrect options are wrong:** * **A. Congenital syphilis:** Presents with Hutchinson teeth, interstitial keratitis, and sensorineural deafness (Saber shins), not skin hyperextensibility. * **C. Vitamin D deficiency:** Causes Rickets in children, characterized by bow legs (genu varum), rachitic rosary, and craniotabes, rather than joint hypermobility or skin laxity. * **D. Multiple congenital anomalies:** This is a non-specific descriptive term and does not account for the specific biochemical defect (tenascin-X) or the systemic connective tissue findings. **High-Yield Pearls for NEET-PG:** * **EDS Type I & II (Classical):** Mutation in **COL5A1/COL5A2** (Type V Collagen). * **EDS Type IV (Vascular):** Mutation in **COL3A1** (Type III Collagen); carries high risk of arterial or organ rupture. * **EDS Type VI (Kyphoscoliotic):** Deficiency of **Lysyl hydroxylase**. * **Key Triad:** Hyperextensible skin, hypermobile joints, and fragile tissues (poor wound healing/easy bruising).

Q: Adrenoleukodystrophy is characterized by which mode of inheritance?

X-linked recessive. **Explanation:** **Adrenoleukodystrophy (X-linked ALD)** is a peroxisomal disorder caused by a mutation in the **ABCD1 gene**, located on the **X chromosome**. This gene encodes the ALD protein (ALDP), a transmembrane protein responsible for transporting **Very Long Chain Fatty Acids (VLCFAs)** into the peroxisomes for degradation via **beta-oxidation**. 1. **Why X-linked Recessive is correct:** The defect follows an X-linked recessive pattern, primarily affecting males. The deficiency of ALDP leads to the systemic accumulation of VLCFAs (especially Hexacosanoic acid, C26:0) in the plasma and tissues. This accumulation is toxic to the **adrenal cortex** (causing adrenal insufficiency/Addison’s disease) and the **myelin sheath** of the central nervous system (leading to progressive demyelination). 2. **Why other options are incorrect:** * **Autosomal Dominant/Recessive:** While some peroxisomal biogenesis disorders (like Zellweger Syndrome) are autosomal recessive, the classic Adrenoleukodystrophy is specifically linked to the X chromosome. * **X-linked Dominant:** ALD does not follow a dominant pattern; carrier females are usually asymptomatic or develop milder, late-onset neurological symptoms (adrenomyeloneuropathy) due to skewed X-inactivation. **High-Yield Clinical Pearls for NEET-PG:** * **Biochemical Marker:** Elevated levels of **VLCFAs** in plasma is the pathognomonic finding. * **Clinical Triad:** Progressive cognitive decline, visual/hearing loss, and adrenal insufficiency (bronzing of skin due to high ACTH). * **MRI Finding:** Symmetrical enhancement of the **posterior white matter** (occipital and parietal lobes). * **Related Disorder:** Do not confuse with **Zellweger Syndrome**, which is an autosomal recessive "peroxisome biogenesis disorder" (defect in PEX genes) affecting all peroxisomal functions.

Q: Menkes Kinky hair syndrome is characterized by congenital deficiency of which of the following?

Copper binding ATPase. **Explanation:** **Menkes Kinky Hair Syndrome** is an X-linked recessive disorder caused by a mutation in the **ATP7A gene**. This gene encodes a **Copper-binding P-type ATPase**, which is essential for the absorption of dietary copper from intestinal mucosal cells into the bloodstream and its transport across the blood-brain barrier. 1. **Why the Correct Answer is Right:** In Menkes disease, the defective **Copper-binding ATPase (ATP7A)** leads to copper being trapped within intestinal cells (enterocytes). Consequently, copper cannot reach the liver or other tissues, resulting in a severe systemic copper deficiency. This impairs copper-dependent enzymes like *Lysyl oxidase* (leading to connective tissue defects) and *Tyrosinase* (leading to hypopigmentation). 2. **Why Incorrect Options are Wrong:** * **Serum Ceruloplasmin & Serum Copper (Options A & B):** While both levels are characteristically **low** in Menkes disease, they are *biochemical findings* (consequences) rather than the primary *congenital deficiency* (the cause). The question asks for the underlying genetic/protein deficiency. * **Ferrochelatase (Option C):** This is the final enzyme in the Heme synthesis pathway. Its deficiency leads to Erythropoietic Protoporphyria, not copper metabolism disorders. **High-Yield Clinical Pearls for NEET-PG:** * **Clinical Triad:** "Steely" or "Kinky" brittle hair (pili torti), progressive neurological degeneration, and connective tissue laxity. * **Enzyme involved:** Defective **Lysyl Oxidase** (requires copper) causes the characteristic hair and vascular abnormalities. * **Menkes vs. Wilson:** * **Menkes:** ATP7A mutation; Copper **deficiency**; Intestinal transport defect. * **Wilson:** ATP7B mutation; Copper **overload**; Biliary excretion defect.

Q: Enzyme replacement therapy is most effective for which of the following inherited metabolic disorders?

Gaucher's disease. **Explanation:** **Gaucher’s disease** is the correct answer because it was the first lysosomal storage disorder (LSD) for which **Enzyme Replacement Therapy (ERT)** was successfully developed and remains the gold standard of treatment. The disease is caused by a deficiency of **β-glucocerebrosidase**, leading to the accumulation of glucosylceramide in macrophages (Gaucher cells). ERT (using recombinant enzymes like Imiglucerase) is highly effective in reversing systemic manifestations such as hepatosplenomegaly and hematological abnormalities (anemia, thrombocytopenia). **Analysis of Incorrect Options:** * **Niemann-Pick Disease:** While ERT (Olipudase alfa) has recently been approved for Type B (non-neuropathic), it is not effective for Type A due to the enzyme's inability to cross the blood-brain barrier. Historically and clinically, Gaucher’s remains the classic example of ERT success. * **Gangliosidosis (e.g., Tay-Sachs):** These primarily affect the Central Nervous System (CNS). Current ERT cannot cross the blood-brain barrier, making it ineffective for the neurodegenerative components of these diseases. * **Phenylketonuria (PKU):** This is an amino acid metabolism disorder, not a lysosomal storage disease. It is primarily managed through **dietary restriction** (low phenylalanine diet) rather than ERT. **High-Yield Clinical Pearls for NEET-PG:** * **Gaucher’s Hallmark:** "Crinkled paper" appearance of macrophage cytoplasm. * **Most Common LSD:** Gaucher’s disease is the most common lysosomal storage disorder. * **Bone Involvement:** Look for "Erlenmeyer flask deformity" of the distal femur and avascular necrosis in Gaucher’s cases. * **ERT Limitation:** The major hurdle for ERT in LSDs is the **Blood-Brain Barrier**; hence, ERT is most effective for non-neuropathic (Type 1) Gaucher’s.

Q: Mitochondrial chromosomal abnormalities lead to which of the following conditions?

Leber's hereditary optic neuropathy. ### Explanation **Mitochondrial inheritance** is a non-Mendelian pattern where mutations occur in the extranuclear mitochondrial DNA (mtDNA) [2]. Since mitochondria are inherited exclusively from the oocyte, these diseases are transmitted only by females to all their offspring, while affected males never pass the condition to their children. #### Why the Correct Answer is Right: **A. Leber's Hereditary Optic Neuropathy (LHON):** This is the classic example of a mitochondrial DNA mutation (typically involving genes for NADH dehydrogenase). It presents as painless, subacute bilateral central vision loss, primarily in young adult males [1]. Other examples of mitochondrial diseases include MELAS, MERRF, and Kearns-Sayre syndrome [1]. #### Why the Other Options are Wrong: * **B & C. Angelman and Prader-Willi Syndromes:** These are examples of **Genomic Imprinting** involving chromosome 15. Prader-Willi results from the loss of the paternal allele, while Angelman results from the loss of the maternal allele (specifically the UBE3A gene). * **D. Myotonic Dystrophy:** This is an **Autosomal Dominant** condition characterized by **Trinucleotide Repeat Expansion** (CTG repeat in the DMPK gene). It exhibits "Anticipation," where the disease becomes more severe in successive generations. #### NEET-PG High-Yield Pearls: * **Heteroplasmy:** A key concept in mitochondrial genetics where a cell contains a mixture of both normal and mutated mtDNA. The severity of the disease depends on the proportion of mutated mitochondria. * **Tissues Affected:** Mitochondrial diseases primarily affect high-energy-demand tissues: the CNS (seizures, stroke-like episodes), Skeletal Muscle (weakness, "Ragged Red Fibers" on Gomori trichrome stain), and the Heart [1]. * **Maternal Inheritance:** If a question mentions a mother passing a trait to all children but the father passing it to none, always think Mitochondrial Inheritance.

Q: NARP syndrome is a disorder of which cellular organelle?

Mitochondria. **Explanation:** **NARP syndrome** (Neurogenic muscle weakness, Ataxia, and Retinitis Pigmentosa) is a classic example of a **mitochondrial DNA (mtDNA) disorder**. It is caused by a point mutation in the **MT-ATP6 gene**, which encodes a subunit of the mitochondrial ATP synthase (Complex V). This mutation impairs the organelle's ability to produce ATP via oxidative phosphorylation, leading to energy failure in tissues with high metabolic demands, such as the nervous system and retina. **Why other options are incorrect:** * **Lysosome:** Lysosomal storage disorders (e.g., Gaucher, Tay-Sachs) typically involve the accumulation of undigested substrates due to enzyme deficiencies, rather than primary ATP production failure. * **Nucleus:** While some mitochondrial proteins are encoded by nuclear DNA, NARP is specifically linked to mutations in the mitochondrial genome itself. * **Cytosol:** The cytosol is the site of glycolysis, but NARP involves the terminal stage of energy production (oxidative phosphorylation) which occurs exclusively within the mitochondria. **High-Yield Clinical Pearls for NEET-PG:** * **Maternal Inheritance:** Like most mtDNA disorders, NARP is inherited exclusively from the mother. * **The Leigh Disease Connection:** NARP and **Leigh Syndrome** (Subacute Necrotizing Encephalomyelopathy) represent a clinical spectrum. If the mutation load (heteroplasmy) is 90%, it manifests as the more severe Leigh Syndrome. * **Key Triad:** Remember the acronym: **N**eurogenic weakness, **A**taxia, **R**etinitis **P**igmentosa. * **Biochemical Marker:** Often associated with elevated lactate levels in blood or CSF due to impaired aerobic metabolism.

Q: All of the following diseases are due to an excessive number of glutamine residues in proteins, EXCEPT?

Myotonic dystrophy. This question tests your knowledge of **Trinucleotide Repeat Expansion** disorders, which are classified based on the specific repeat sequence and its location within the gene. ### **Explanation** The diseases listed are all trinucleotide repeat disorders, but they differ in the type of repeat: 1. **Myotonic Dystrophy (Type 1):** This is the correct answer because it is caused by a **CTG** repeat expansion in the 3' untranslated region (UTR) of the *DMPK* gene. Since the expansion occurs in a non-coding region, it does not result in a polyglutamine (polyQ) chain. Instead, it causes disease through RNA toxicity. 2. **Polyglutamine (polyQ) Diseases:** Options A, B, and D are all caused by **CAG** repeats within the **coding region (exon)** of the gene. In the genetic code, CAG codes for the amino acid **Glutamine**. Therefore, an expansion of CAG repeats leads to an abnormally long chain of glutamine residues in the protein, causing it to misfold and become toxic to neurons. * **Huntington’s Chorea:** CAG repeat in the *Huntingtin* gene. * **Spinocerebellar Ataxia (SCA):** Multiple types (e.g., SCA1, 2, 3) involve CAG repeats. * **Spinobulbar Muscular Atrophy (Kennedy Disease):** CAG repeat in the *Androgen Receptor* gene. ### **NEET-PG High-Yield Pearls** * **Anticipation:** This phenomenon, where the disease becomes more severe or has an earlier onset in successive generations, is a hallmark of trinucleotide repeat disorders. * **Friedreich Ataxia:** Unique because it is an **Autosomal Recessive** trinucleotide disorder (GAA repeat). * **Fragile X Syndrome:** Caused by **CGG** repeats in the 5' UTR of the *FMR1* gene, leading to gene silencing via methylation. * **Mnemonic for CAG (PolyQ):** "**H**untington **S**ings **A**t **B**ars" (**H**untington, **S**pinocerebellar Ataxia, **A**ndrogen receptor/Spinobulbar **B**ulbar atrophy).

Q: Increased ammonia level, normal pH, and high anion gap acidosis is seen in which of the following conditions?

Organic acidemia. **Explanation:** The clinical triad of **hyperammonemia, metabolic acidosis, and a high anion gap (HAGMA)** is the hallmark of **Organic Acidemias** (e.g., Methylmalonic acidemia, Propionic acidemia). 1. **Why Organic Acidemia is correct:** In these disorders, the accumulation of organic acid intermediates (like methylmalonate or propionate) directly increases the unmeasured anions, leading to **HAGMA**. Hyperammonemia occurs secondary to the inhibition of **N-acetylglutamate synthase (NAGS)** by the accumulated organic acyl-CoA esters. NAGS is essential for producing N-acetylglutamate, the obligatory activator of Carbamoyl Phosphate Synthetase I (CPS-I), the first step of the urea cycle. Thus, the urea cycle is "choked," leading to elevated ammonia. 2. **Why other options are incorrect:** * **Urea Cycle Defects:** These typically present with **severe hyperammonemia and respiratory alkalosis** (due to ammonia-induced hyperventilation). They do *not* cause a high anion gap metabolic acidosis. * **Galactosemia:** Presents with jaundice, hepatosplenomegaly, and cataracts. While it can cause a tubular acidosis (Fanconi syndrome), it does not typically present with the acute HAGMA/hyperammonemia triad. * **Alkaptonuria:** A relatively benign condition characterized by ochronosis (darkening of tissues) and dark urine upon standing. It does not cause acute metabolic crises or hyperammonemia. **High-Yield Clinical Pearls for NEET-PG:** * **Differentiating Factor:** If a neonate has hyperammonemia **without** acidosis, think Urea Cycle Disorder. If hyperammonemia is accompanied by **ketosis and HAGMA**, think Organic Acidemia. * **Common Enzyme Deficiencies:** Propionic acidemia (Propionyl-CoA carboxylase deficiency) and Methylmalonic acidemia (Methylmalonyl-CoA mutase deficiency). * **Management:** Immediate restriction of protein intake and administration of glucose to prevent catabolism.

Q: The gene for the folate carrier protein is located on which chromosome?

Chromosome 21. **Explanation:** The correct answer is **Chromosome 21**. The gene responsible for the **Reduced Folate Carrier 1 (RFC1)**, also known as SLC19A1, is located on the long arm of chromosome 21 (21q22.3). This protein is the primary transporter for moving folate (Vitamin B9) from the extracellular space into the cytoplasm. **Why Chromosome 21 is correct:** The localization of the folate carrier gene on Chromosome 21 has significant clinical implications in **Down Syndrome (Trisomy 21)**. Individuals with Down Syndrome have three copies of this gene, leading to increased expression of the folate transporter. This altered dosage affects intracellular folate pharmacokinetics, which is why children with Down Syndrome often exhibit increased sensitivity to folate antagonists like **Methotrexate** (used in treating ALL). **Analysis of Incorrect Options:** * **Chromosome 5:** Associated with the *MSH2* gene (Lynch syndrome) and the *APC* gene (Familial Adenomatous Polyposis), but not primary folate transport. * **Chromosome 10:** Contains the *PTEN* tumor suppressor gene. * **Chromosome 9:** Location of the *ABL* gene (translocated in Philadelphia chromosome) and the *FRDA* gene (Friedreich's ataxia). **High-Yield Clinical Pearls for NEET-PG:** 1. **Gene Dosage Effect:** The overexpression of RFC1 in Trisomy 21 leads to higher intracellular concentrations of methotrexate polyglutamates, increasing drug toxicity. 2. **Folate Metabolism:** Folate is essential for DNA synthesis (purine and pyrimidine synthesis). Deficiency leads to **Megaloblastic Anemia** and **Neural Tube Defects (NTDs)**. 3. **Absorption:** While RFC1 handles cellular uptake, the **Proton-Coupled Folate Transporter (PCFT)** on Chromosome 17 is responsible for intestinal folate absorption.

Question 1

A 4-year-old girl presents with sudden onset of right hip pain. Examination reveals a dislocated right hip. She can bend her thumb backward to touch her forearm, and her skin is extraordinarily stretchable. Spinal radiographs show marked lateral and anterior curvature. She develops retinal detachments later in childhood. A sibling is similarly affected, and a mutation in tenascin-X is identified. What is the most likely underlying cause for this child's findings?

Accepted Answer

Deficient collagen synthesis

Answer

Congenital syphilis

Answer

Diet lacking in vitamin D

Answer

Multiple congenital anomalies

Question 2

Renal manifestations are seen in all of the following metabolic disorders EXCEPT?

Accepted Answer

Phenylketonuria

Answer

Tyrosinemia

Answer

Galactosemia

Answer

Hereditary fructose intolerance

Question 3

Adrenoleukodystrophy is characterized by which mode of inheritance?

Accepted Answer

X-linked recessive

Answer

Autosomal dominant

Answer

Autosomal recessive

Answer

X-linked dominant

Question 4

Menkes Kinky hair syndrome is characterized by congenital deficiency of which of the following?

Accepted Answer

Copper binding ATPase

Answer

Serum ceruloplasmin

Answer

Serum copper

Answer

Ferochelatase

Question 5

Enzyme replacement therapy is most effective for which of the following inherited metabolic disorders?

Accepted Answer

Gaucher's disease

Answer

Niemann-Pick disease

Answer

Gangliosidosis

Answer

Phenylketonuria

Question 6

Mitochondrial chromosomal abnormalities lead to which of the following conditions?

Accepted Answer

Leber's hereditary optic neuropathy

Answer

Angelman syndrome

Answer

Prader-Willi syndrome

Answer

Myotonic dystrophy

Question 7

NARP syndrome is a disorder of which cellular organelle?

Accepted Answer

Mitochondria

Answer

Lysosome

Answer

Nucleus

Answer

Cytosol

Question 8

All of the following diseases are due to an excessive number of glutamine residues in proteins, EXCEPT?

Accepted Answer

Myotonic dystrophy

Answer

Huntington's chorea

Answer

Spinocerebellar ataxia

Answer

Spinobulbar muscular atrophy

Question 9

Increased ammonia level, normal pH, and high anion gap acidosis is seen in which of the following conditions?

Accepted Answer

Organic acidemia

Answer

Urea cycle defects

Answer

Galactosemia

Answer

Alkaptonuria

Question 10

The gene for the folate carrier protein is located on which chromosome?

Accepted Answer

Chromosome 21

Answer

Chromosome 5

Answer

Chromosome 10

Answer

Chromosome 9

Genetic Disorders and Biochemical Pathology — MCQs

Genetic Disorders and Biochemical Pathology — MCQs

On this page

Practice by Chapter

Want unlimited practice?